Stay updated with breaking news from Formation Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PARIS (dpa-AFX) - French drug major Sanofi is teaming with artificial intelligence or AI startup OpenAI, the developer of highly popular generative AI chatbot ChatGPT, as well as Formation Bio
Read Latest Technology News Quickly Here | French drugmaker Sanofi on Tuesday announced that it has partnered with artificial intelligence (AI) company OpenAI and tech-driven pharmaceutical firm Formation Bio to build AI-powered software to boost drug development and bring new medicines to patients more efficiently.
Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently. The three teams will bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle.
Sanofi collaborates with OpenAI and Formation Bio to enhance drug development. The partnership leverages proprietary data, advanced AI models, and engineering expertise to accelerate the biopharma lifecycle.
JD.com, Inc. (JD), a supply chain-based technology and service provider, on Tuesday announced a proposed offering of convertible Senior Notes of $1.5 billion due 2029.